Dashboard
Manage Tickers

ABSI Absci Corp

Nasdaq absci.com


$ 2.66 $ -0.76 (-22.35 %)    

Thursday, 13-Nov-2025 18:52:00 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 608.50 $ -12.68 (-2.04 %)
DIA $ 475.26 $ -8.02 (-1.66 %)
SPY $ 672.50 $ -8.41 (-1.24 %)
TLT $ 89.42 $ -0.74 (-0.82 %)
GLD $ 384.90 $ -3.12 (-0.81 %)
$ 2.64
$ 3.00
$ 2.65 x 1,010
$ 2.70 x 171
$ 2.60 - $ 3.06
$ 2.01 - $ 6.33
18,152,102
na
396.98M
$ 2.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 03-18-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 03-21-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 03-30-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-22-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 09-07-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
11/13/2025 17:06:18

ardent-health-kindercare-learning-ibotta-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Ardent Health, KinderCare Learning, Ibotta...
11/13/2025 13:29:13

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
11/13/2025 12:06:08

needham-maintains-buy-on-absci-lowers-price-target-to-7
Needham Maintains Buy on Absci, Lowers Pri...
11/13/2025 10:46:52

Needham analyst Gil Blum maintains Absci (NASDAQ:ABSI) with a Buy and lowers the price target from $8 to $7.

absci-q3-eps-020-beats-021-estimate-sales-378000k-miss-1644m-estimate
Absci Q3 EPS $(0.20) Beats $(0.21) Estimat...
11/12/2025 21:09:37

Absci (NASDAQ:ABSI) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.21) by 5.66...

earnings-scheduled-for-november-12-2025
Earnings Scheduled For November 12, 2025
11/12/2025 11:11:28

absci-to-host-december-11-seminar-on-abs-201-for-androgenetic-alopecia-phase-12a-trial-now-expected-to-begin-in-december-ahead-of-prior-guidance
Absci To Host December 11 Seminar On ABS-2...
10/15/2025 12:08:18

Webinar on December 11 to feature leading KOLs in dermatology and hair loss alongside Absci leadershipPhase 1/2a trial now expe...

dell-select-medical-century-aluminum-and-other-big-stocks-moving-higher-on-wednesday
Dell, Select Medical, Century Aluminum And...
10/08/2025 14:39:06

this-synopsys-analyst-begins-coverage-on-a-bearish-note-here-are-top-5-initiations-for-thursday
This Synopsys Analyst Begins Coverage On A...
10/02/2025 18:26:09

jp-morgan-initiates-coverage-on-absci-with-overweight-rating
JP Morgan Initiates Coverage On Absci with...
10/02/2025 11:18:00

JP Morgan analyst Brian Cheng initiates coverage on Absci (NASDAQ:ABSI) with a Overweight rating.

absci-boosts-ai-powered-drug-discovery-with-oracle-and-amd-collaboration
Absci Boosts AI-Powered Drug Discovery Wit...
09/11/2025 16:10:59

Absci teams up with Oracle and AMD to enhance AI-driven drug discovery using high-performance GPUs.

absci-to-utilize-oracle-cloud-infrastructure-and-amd-hardware-for-ai-driven-drug-discovery
Absci To Utilize Oracle Cloud Infrastructu...
09/11/2025 12:01:19

morgan-stanley-maintains-overweight-on-absci-lowers-price-target-to-589
Morgan Stanley Maintains Overweight on Abs...
08/18/2025 12:59:45

Morgan Stanley analyst Vikram Purohit maintains Absci (NASDAQ:ABSI) with a Overweight and lowers the price target from $6.4 ...

needham-maintains-buy-on-absci-lowers-price-target-to-8
Needham Maintains Buy on Absci, Lowers Pri...
08/13/2025 10:00:29

Needham analyst Gil Blum maintains Absci (NASDAQ:ABSI) with a Buy and lowers the price target from $9 to $8.

absci-q2-eps-024-misses-021-estimate-sales-593000k-miss-1427m-estimate
Absci Q2 EPS $(0.24) Misses $(0.21) Estima...
08/12/2025 20:06:01

Absci (NASDAQ:ABSI) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.21) by 14...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

abscis-earnings-a-preview
Absci's Earnings: A Preview
08/11/2025 15:02:41

almirall-selects-second-target-in-absci-collaboration-to-accelerate-ai-driven-therapeutics-for-severe-skin-conditions
Almirall Selects Second Target In Absci Co...
08/07/2025 06:48:46

Almirall selects second target in AI Drug Creation collaborationExpanded collaboration builds on Absci's successful de novo...

morgan-stanley-maintains-overweight-on-absci-lowers-price-target-to-64
Morgan Stanley Maintains Overweight on Abs...
07/28/2025 12:54:36

Morgan Stanley analyst Vikram Purohit maintains Absci (NASDAQ:ABSI) with a Overweight and lowers the price target from $7 to...

cathie-woods-ark-invest-loads-up-on-absci-offloads-crispr-therapeutics
Cathie Wood's Ark Invest Loads Up On Absci...
07/26/2025 05:25:42

Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION